Encompass Health (EHC) Cost of Revenue (2009 - 2026)

Encompass Health (EHC) has 18 years of Cost of Revenue data on file, last reported at $64.3 million in Q1 2026.

• Quarterly Cost of Revenue rose 3.38% year-over-year to $64.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $418.3 million (up 329.91% YoY) and the FY2025 annual result came in at $888.7 million, up 271.84% from the prior year.
• Cost of Revenue fell to $64.3 million in Q1 2026, from $226.3 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $226.3 million in Q4 2025 to a low of -$357.2 million in Q4 2024.
• A 5-year average of $75.6 million and a median of $64.6 million in 2025 frame the typical range for Cost of Revenue.
• The widest YoY moves for Cost of Revenue: up 268.31% in 2022, down 718.67% in 2022.
• Tracing EHC's Cost of Revenue over 5 years: stood at -$298.2 million in 2022, then surged by 119.65% to $58.6 million in 2023, then sank by 709.56% to -$357.2 million in 2024, then surged by 163.35% to $226.3 million in 2025, then sank by 71.59% to $64.3 million in 2026.
• The last three Cost of Revenue figures came in at $64.3 million (Q1 2026), $226.3 million (Q4 2025), and $64.6 million (Q3 2025), per Business Quant data.